The colorectal tumors that were developed in Sphk2−/− mice showed great sensitivity to 5-FU therapy, indicating that high SPHK2 expression in colorectal tumors yields resistance to 5-FU chemotherapy treatment [22]. This evidence concerns the gene SPHK2 and colorectal neoplasm.